1-11 of 11
basic local alignment search tool
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Clinical Trials & Observations
Ifeyinwa Emmanuela Obiorah, Bhavisha A. Patel, Emma M. Groarke, Weixin Wang, Megan Trick, Amanda K. Ombrello, Marcela A. Ferrada, Zhijie Wu, Fernanda Gutierrez-Rodrigues, Jennifer Lotter, Lorena Wilson, Patrycja Hoffmann, Daniela Ospina Cardona, Nisha Patel, Alina Dulau-Florea, Daniel L. Kastner, Peter C. Grayson, David B. Beck, Neal S. Young, Katherine R. Calvo
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3203–3215.
https://doi.org/10.1182/bloodadvances.2021004976
Published: 2021
Includes: Supplemental data
Journal Articles

Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL– negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.

Journal: Blood Advances
Blood Adv (2021) 5 (11): 2518.
https://doi.org/10.1182/bloodadvances.2021005068
Published: 2021
Journal Articles

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Clinical Trials & Observations
Vikas Gupta, James A. Kennedy, Jose-Mario Capo-Chichi, Soyoung Kim, Zhen-Huan Hu, Edwin P. Alyea, Uday R. Popat, Ronald M. Sobecks, Bart L. Scott, Aaron T. Gerds, Rachel B. Salit, H. Joachim Deeg, Ryotara Nakamura, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5562–5573.
https://doi.org/10.1182/bloodadvances.2020002727
Published: 2020
Includes: Supplemental data
Journal Articles

Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms

Clinical Trials & Observations
Michael A. Spinner, Alexey Aleshin, Marianne T. Santaguida, Steven A. Schaffert, James L. Zehnder, A. Scott Patterson, Christos Gekas, Diane Heiser, Peter L. Greenberg
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2768–2778.
https://doi.org/10.1182/bloodadvances.2020001934
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Clinical Trials & Observations
Je-Hwan Lee, Stefan Faderl, John M. Pagel, Chul Won Jung, Sung-Soo Yoon, Animesh D. Pardanani, Pamela S. Becker, Howard Lee, Jeongeun Choi, Kyoungjune Lee, Minkyoung Kim, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2032–2043.
https://doi.org/10.1182/bloodadvances.2019000757
Published: 2020
Includes: Supplemental data
Journal Articles

Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome

Emily F. Mason, Robert P. Hasserjian, Nidhi Aggarwal, Adam C. Seegmiller, Olga Pozdnyakova
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3322–3332.
https://doi.org/10.1182/bloodadvances.2019000328
Published: 2019
Includes: Supplemental data
Journal Articles

Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes

Kazuaki Yokoyama, Eigo Shimizu, Nozomi Yokoyama, Sousuke Nakamura, Rika Kasajima, Miho Ogawa, Tomomi Takei, Mika Ito, Asako Kobayashi, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Arinobu Tojo
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2513–2521.
https://doi.org/10.1182/bloodadvances.2017010744
Published: 2018
Includes: Supplemental data
Journal Articles

A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia

Clinical Trials & Observations
Lili Aslostovar, Allison L. Boyd, Mohammed Almakadi, Tony J. Collins, Darryl P. Leong, Rommel G. Tirona, Richard B. Kim, Jim A. Julian, Anargyros Xenocostas, Brian Leber, Mark N. Levine, Ronan Foley, Mickie Bhatia
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1935–1945.
https://doi.org/10.1182/bloodadvances.2018015677
Published: 2018
Includes: Supplemental data
Journal Articles

Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories

Clinical Trials & Observations
Sanam Loghavi, Dawen Sui, Peng Wei, Guillermo Garcia-Manero, Sherry Pierce, Mark J. Routbort, Elias J. Jabbour, Naveen Pemmaraju, Rashmi Kanagal-Shamanna, H. Deniz Gur, Shimin Hu, Zhuang Zuo, L. Jeffrey Medeiros, Hagop M. Kantarjian, Joseph D. Khoury
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1807–1816.
https://doi.org/10.1182/bloodadvances.2018019224
Published: 2018
Includes: Supplemental data
Journal Articles

Targeted next-generation sequencing in blast phase myeloproliferative neoplasms

Clinical Trials & Observations
Terra L. Lasho, Mythri Mudireddy, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Natasha Szuber, Kebede H. Begna, Mrinal M. Patnaik, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2018) 2 (4): 370–380.
https://doi.org/10.1182/bloodadvances.2018015875
Published: 2018
Includes: Supplemental data
Journal Articles

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes

Clinical Trials & Observations
Chi-Yuan Yao, Ching-Hsuan Chen, Huai-Hsuan Huang, Hsin-An Hou, Chien-Chin Lin, Mei-Hsuan Tseng, Chein-Jun Kao, Tzu-Pin Lu, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1505–1516.
https://doi.org/10.1182/bloodadvances.2017008284
Published: 2017
Includes: Supplemental data